Transfusion 2012,52(7):1404–1407 PubMedCrossRef 75 Meng W, Yamaz

Transfusion 2012,52(7):1404–1407.PubMedCrossRef 75. Meng W, Yamazaki T, Nishida Y, Hanagata N: Nuclease-resistant immunostimulatory phosphodiester CpG oligodeoxynucleotides as human Toll-like receptor 9 agonists. BMC Biotechnol 2011, 11:88.PubMedCentralPubMedCrossRef 76. Mutwiri GK, Nichani AK, Babiuk S, Babiuk LA: Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides. J Control Release 2004,97(1):1–17.PubMedCrossRef 77. Monno R, Fumarola L, Mercadante G, Tzakis G, Battista M, Miragliotta G: Evaluation of a rapid test for the diagnosis of pneumococcal pneumonia. J Microbiol Methods 2013,92(2):127–131.PubMedCrossRef 78.

Tokarz R, Kapoor V, Samuel JE, Bouyer DH, Briese T, Lipkin WI: Detection CFTRinh-172 cell line of tick-borne pathogens by MassTag polymerase chain reaction. Vector Borne Zoonotic Dis 2009,9(2):147–152.PubMedCrossRef 79. Liveris D, Schwartz I, McKenna D, Nowakowski J, Nadelman RB, DeMarco J, Iyer R, Cox ME, Holmgren D, Wormser GP: Quantitation of cell-associated borrelial DNA in the blood of Lyme disease patients with erythema migrans. Eur J Clin Microbiol Infect Dis 2012,31(5):791–795.PubMedCrossRef 80. Eshoo MW, Crowder CC, Rebman AW, Rounds NVP-BSK805 in vitro MA, Matthews HE, Picuri JM, Soloski MJ, Ecker DJ, Schutzer SE, Aucott JN: Direct molecular detection and genotyping of Borrelia PKC inhibitor burgdorferi from whole blood of patients

with early Lyme disease. PLoS One 2012,7(5):e36825.PubMedCentralPubMedCrossRef 81. Horowitz HW, Aguero-Rosenfeld ME, Holmgren D, McKenna D, Schwartz I, Cox ME, Wormser GP: Lyme disease and human granulocytic anaplasmosis coinfection: impact of case definition on coinfection rates and illness severity. Clin Infect Dis 2013,56(1):93–99.PubMedCrossRef 82. Dominguez SR, Briese T, Palacios G, Hui J, Villari J, Kapoor V, Tokarz R, Glode MP, Anderson MS, Robinson CC, et al.: Multiplex mafosfamide MassTag-PCR for respiratory pathogens in pediatric nasopharyngeal washes negative by conventional diagnostic testing shows a high prevalence of viruses belonging to a newly recognized rhinovirus clade. J Clin Virol 2008,43(2):219–222.PubMedCentralPubMedCrossRef 83. Ferdin

J, Cerar T, Strle F, Ruzic-Sabljic E: Evaluation of real-time PCR targeting hbb gene for Borrelia species identification. J Microbiol Methods 2010,82(2):115–119.PubMedCrossRef 84. Iyer R, Mukherjee P, Wang K, Simons J, Wormser GP, Schwartz I: Detection of Borrelia burgdorferi nucleic acids after antibiotic treatment does not confirm viability. J Clin Microbiol 2013,51(3):857–862.PubMedCentralPubMedCrossRef 85. Liveris D, Schwartz I, Bittker S, Cooper D, Iyer R, Cox ME, Wormser GP: Improving the yield of blood cultures from patients with early Lyme disease. J Clin Microbiol 2011,49(6):2166–2168.PubMedCentralPubMedCrossRef 86. Liveris D, Schwartz I, McKenna D, Nowakowski J, Nadelman R, Demarco J, Iyer R, Bittker S, Cooper D, Holmgren D, et al.

Comments are closed.